Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-01-07 Sale | 2019-01-07 8:36 pm | IMMUNE DESIGN CORP. | IMDZ | Paya Carlos V President and CEO | 13,014 | $1.5822 | $20,591 | 449,576 (Direct) | View |
| 2019-01-07 Sale | 2019-01-07 8:35 pm | IMMUNE DESIGN CORP. | IMDZ | ter Meulen Jan Henrik Chief Scientific Officer | 3,414 | $1.586 | $5,415 | 203,982 (Direct) | View |
| 2019-01-07 Sale | 2019-01-07 8:34 pm | IMMUNE DESIGN CORP. | IMDZ | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | 3,522 | $1.5717 | $5,536 | 188,756 (Direct) | View |
| 2019-01-07 Sale | 2019-01-07 8:33 pm | IMMUNE DESIGN CORP. | IMDZ | Brady Stephen R EVP, Strategy & Finance | 5,516 | $1.5812 | $8,722 | 216,599 (Direct) | View |
| 2018-12-04 Sale | 2018-12-04 9:59 pm | IMMUNE DESIGN CORP. | IMDZ | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner | 902,000 | $1.8336 | $1,653,907 | 370,391 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-04-02 Disposition | 2019-04-04 5:24 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | BERGER FRANKLIN M Director | 75,000 | $5.85 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:24 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | BERGER FRANKLIN M Director | 35,000 | $0 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:17 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | BALTIMORE DAVID Director | 78,287 | $5.85 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:17 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | BALTIMORE DAVID Director | 42,339 | $0 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:16 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | 6,136 | $5.85 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:16 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | 405,955 | $0 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:15 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | Brady Stephen R EVP, Strategy & Finance | 17,063 | $5.85 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:15 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | Brady Stephen R EVP, Strategy & Finance | 600,719 | $0 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:14 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | Gombotz Wayne Chief Development Officer | 166,086 | $0 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:14 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | Paya Carlos V President and CEO | 35,576 | $5.85 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:14 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | Paya Carlos V President and CEO | 1,636,884 | $0 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:13 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | ter Meulen Jan Henrik Chief Scientific Officer | 14,620 | $5.85 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:13 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | ter Meulen Jan Henrik Chief Scientific Officer | 494,987 | $0 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:12 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | Kelley Susan L. Director | 35,000 | $0 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:11 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | PENHOET EDWARD Director | 42,339 | $0 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:10 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | RINGO WILLIAM R Director | 35,000 | $0 | 0 (Direct) | View |
| 2019-04-02 Disposition | 2019-04-04 5:06 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | COLEMAN LEWIS W Director | 178,000 | $5.85 | 0 (Indirect) | View |
| 2019-04-02 Disposition | 2019-04-04 5:06 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | COLEMAN LEWIS W Director | 35,000 | $0 | 0 (Direct) | View |
| 2019-04-02 Equity Swap | 2019-04-02 8:57 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP II LP Column Group II GP LP PONOI CAPITAL LP Ponoi Management LLC GOEDDEL DAVID V Kutzkey Tim Svennilson Peter 10% Owner | 6,642,942 | $5.85 | 0 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-07 8:36 pm | N/A 2029-01-03 | IMMUNE DESIGN CORP. | IMDZ | Paya Carlos V President and CEO | 356,000 | $0 | 449,576 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-07 8:35 pm | N/A 2029-01-03 | IMMUNE DESIGN CORP. | IMDZ | ter Meulen Jan Henrik Chief Scientific Officer | 145,000 | $0 | 203,982 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-07 8:34 pm | N/A 2029-01-03 | IMMUNE DESIGN CORP. | IMDZ | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | 135,000 | $0 | 188,756 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-07 8:33 pm | N/A 2029-01-03 | IMMUNE DESIGN CORP. | IMDZ | Brady Stephen R EVP, Strategy & Finance | 145,000 | $0 | 216,599 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-07 8:19 pm | N/A 2029-01-03 | IMMUNE DESIGN CORP. | IMDZ | COLEMAN LEWIS W Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-07 8:18 pm | N/A 2029-01-03 | IMMUNE DESIGN CORP. | IMDZ | RINGO WILLIAM R Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-07 8:17 pm | N/A 2029-01-03 | IMMUNE DESIGN CORP. | IMDZ | BERGER FRANKLIN M Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-07 8:16 pm | N/A 2029-01-03 | IMMUNE DESIGN CORP. | IMDZ | BALTIMORE DAVID Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-07 8:15 pm | N/A 2029-01-03 | IMMUNE DESIGN CORP. | IMDZ | Kelley Susan L. Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-07 8:14 pm | N/A 2029-01-03 | IMMUNE DESIGN CORP. | IMDZ | PENHOET EDWARD Director | 12,500 | $0 | 12,500 (Direct) | View |
Ownership | 2018-11-09 6:27 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 5,717,913 (Direct) | View |
| 2018-11-07 Option Award | 2018-11-09 4:15 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | ter Meulen Jan Henrik Chief Scientific Officer | 23,362 | $0 | 62,396 (Direct) | View |
| 2018-11-07 Option Award | 2018-11-09 4:14 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | Brady Stephen R EVP, Strategy & Finance | 29,953 | $0 | 77,115 (Direct) | View |
| 2018-11-07 Option Award | 2018-11-09 4:13 pm | N/A N/A | IMMUNE DESIGN CORP. | IMDZ | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | 29,953 | $0 | 57,278 (Direct) | View |
| 2018-07-17 Option Award | 2018-07-19 6:06 pm | N/A 2025-07-17 | IMMUNE DESIGN CORP. | IMDZ | Brady Stephen R EVP, Strategy & Finance | 184,364 | $0 | 184,364 (Direct) | View |
| 2018-07-17 Disposition | 2018-07-19 6:06 pm | N/A 2024-06-23 | IMMUNE DESIGN CORP. | IMDZ | Brady Stephen R EVP, Strategy & Finance | 299,755 | $0 | 184,364 (Direct) | View |
| 2018-07-17 Option Award | 2018-07-19 6:05 pm | N/A 2025-07-17 | IMMUNE DESIGN CORP. | IMDZ | Paya Carlos V President and CEO | 263,009 | $0 | 263,009 (Direct) | View |
| 2018-07-17 Disposition | 2018-07-19 6:05 pm | N/A 2024-06-23 | IMMUNE DESIGN CORP. | IMDZ | Paya Carlos V President and CEO | 444,510 | $0 | 263,009 (Direct) | View |
| 2018-07-17 Option Award | 2018-07-19 6:03 pm | N/A 2025-07-17 | IMMUNE DESIGN CORP. | IMDZ | Gombotz Wayne Chief Development Officer | 68,454 | $0 | 68,454 (Direct) | View |
| 2018-07-17 Disposition | 2018-07-19 6:03 pm | N/A 2025-01-07 | IMMUNE DESIGN CORP. | IMDZ | Gombotz Wayne Chief Development Officer | 115,000 | $0 | 68,454 (Direct) | View |
| 2018-07-17 Option Award | 2018-07-19 6:02 pm | N/A 2025-07-17 | IMMUNE DESIGN CORP. | IMDZ | ter Meulen Jan Henrik Chief Scientific Officer | 46,788 | $0 | 46,788 (Direct) | View |
| 2018-07-17 Disposition | 2018-07-19 6:02 pm | N/A 2025-01-07 | IMMUNE DESIGN CORP. | IMDZ | ter Meulen Jan Henrik Chief Scientific Officer | 85,000 | $0 | 46,788 (Direct) | View |
| 2018-07-17 Option Award | 2018-07-19 6:01 pm | N/A 2025-07-17 | IMMUNE DESIGN CORP. | IMDZ | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | 113,335 | $0 | 113,335 (Direct) | View |
| 2018-07-17 Disposition | 2018-07-19 6:01 pm | N/A 2025-10-01 | IMMUNE DESIGN CORP. | IMDZ | Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | 170,000 | $0 | 113,335 (Direct) | View |